ENTPD2
Basic information
Region (hg38): 9:137048107-137054061
Previous symbols: [ "CD39L1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ENTPD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 59 | 64 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 0 | |||||
Total | 0 | 1 | 59 | 4 | 3 |
Variants in ENTPD2
This is a list of pathogenic ClinVar variants found in the ENTPD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-137048700-A-C | not specified | Uncertain significance (Feb 07, 2025) | ||
9-137048701-G-C | not specified | Uncertain significance (Feb 07, 2025) | ||
9-137048707-C-T | Benign (Dec 31, 2019) | |||
9-137048716-C-T | not specified | Uncertain significance (Oct 29, 2021) | ||
9-137048779-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
9-137048787-G-A | not specified | Uncertain significance (Aug 15, 2023) | ||
9-137048803-T-C | not specified | Uncertain significance (Nov 11, 2024) | ||
9-137048820-A-G | not specified | Uncertain significance (Mar 29, 2024) | ||
9-137048824-T-G | not specified | Uncertain significance (Mar 14, 2023) | ||
9-137048835-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
9-137048856-G-C | not specified | Likely benign (Jan 16, 2024) | ||
9-137048936-C-T | Likely benign (Nov 01, 2022) | |||
9-137048960-C-G | not specified | Uncertain significance (Jul 13, 2021) | ||
9-137048961-C-T | not specified | Uncertain significance (Nov 23, 2022) | ||
9-137048964-C-G | not specified | Uncertain significance (Dec 10, 2024) | ||
9-137048984-C-T | not specified | Uncertain significance (Mar 10, 2025) | ||
9-137048991-C-G | not specified | Uncertain significance (Aug 21, 2023) | ||
9-137048999-A-G | not specified | Uncertain significance (Nov 26, 2024) | ||
9-137049024-C-T | not specified | Uncertain significance (Jul 20, 2022) | ||
9-137049048-C-A | not specified | Uncertain significance (Jun 22, 2021) | ||
9-137049050-C-G | not specified | Uncertain significance (Jun 22, 2021) | ||
9-137049051-G-A | not specified | Uncertain significance (Mar 02, 2023) | ||
9-137049054-GC-G | Susceptibility to severe COVID-19 | Likely pathogenic (Jul 22, 2024) | ||
9-137049068-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
9-137049932-C-T | not specified | Uncertain significance (Jun 16, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ENTPD2 | protein_coding | protein_coding | ENST00000355097 | 9 | 5948 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.46e-14 | 0.0132 | 125593 | 1 | 64 | 125658 | 0.000259 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.659 | 299 | 269 | 1.11 | 0.0000154 | 3125 |
Missense in Polyphen | 110 | 102.81 | 1.0699 | 1330 | ||
Synonymous | -0.453 | 123 | 117 | 1.05 | 0.00000694 | 1074 |
Loss of Function | -0.0940 | 21 | 20.5 | 1.02 | 0.00000114 | 209 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000367 | 0.000364 |
Ashkenazi Jewish | 0.000306 | 0.000298 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.000280 | 0.000277 |
European (Non-Finnish) | 0.000403 | 0.000343 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000166 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: In the nervous system, could hydrolyze ATP and other nucleotides to regulate purinergic neurotransmission. Hydrolyzes ADP only to a marginal extent. The order of activity with different substrates is ATP > GTP > CTP = ITP > UTP >> ADP = UDP.;
- Pathway
- Purine metabolism - Homo sapiens (human);Taste transduction - Homo sapiens (human);Nucleobase catabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NTPDase proteins;Metabolism;Purine nucleotides nucleosides metabolism
(Consensus)
Recessive Scores
- pRec
- 0.155
Intolerance Scores
- loftool
- 0.897
- rvis_EVS
- 0.2
- rvis_percentile_EVS
- 67.3
Haploinsufficiency Scores
- pHI
- 0.262
- hipred
- N
- hipred_score
- 0.238
- ghis
- 0.550
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.365
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Entpd2
- Phenotype
- taste/olfaction phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;purine ribonucleoside diphosphate catabolic process;platelet activation;nucleobase-containing small molecule catabolic process
- Cellular component
- basement membrane;endoplasmic reticulum membrane;plasma membrane;integral component of membrane;extracellular exosome
- Molecular function
- ATP binding;nucleoside-diphosphatase activity;nucleoside-triphosphatase activity